Website profile

@Oncodaily

OncoDaily is a specialized oncology news and information platform that provides daily updates on oncology research, treatments, clinical trials, and advancements in cancer care. It serves healthcare professionals, researchers, and patients by delivering timely and accurate insights into the latest developments in the f

  • 8,320articles · 365d
  • 2+ hour agolatest article
  • Nov 7, 2025earliest in window
  • 21%with images · 230 videos
  • 179avg words
articles per day
Categories
  • Health & Wellness 8,128
  • Medical 7,882
  • Health 7,553
  • Human Interest 320
  • Education & Jobs 251
  • Science & Technology 215
  • Education 90
  • Business & Industrial 53

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Oncodaily - Oncology News
oncodaily.com > voices > steve-koontz-breast-cancer-583147

Steve Koontz: Male Breast Cancer Burden on the Increase in Europe - OncoDaily

3+ day, 21+ hour ago   (196+ words) Steve Koontz, Commission Sales Associate at Hand and Hand Medical, shared on LinkedIn: “Male breast cancer rates are on the rise across Europe, highlighting a critical truth: post-mastectomy recovery challenges know no gender. Whether a patient is female or male,…...

Oncodaily - Oncology News
oncodaily.com > new-paper-alert > jasmin-hundal-breast-cancer-581807

Jasmin Hundal: New Study Reveals Breast Cancer Disparities Among South Asian American Women - OncoDaily

6+ day, 13+ hour ago   (231+ words) “Our new study, ‘Disparities in Breast Cancer Diagnosis, Treatment, and Outcomes Among South Asian American Women’ was published today in Cancers. Authors: Jasmin Hundal, Ishan Gupta, Ashiya Loomba, Yanwen Chen, Halle Moore, Sudipto Mukherjee, Abhay Singh Read The Full Article....

Google News
oncodaily.com > oncolibrary > breast-oncology > iza-bren-panku-breast01

Iza-Bren Reaches the Phase III PFS Endpoint in HR+/HER2??? Advanced Breast Cancer: Why PANKU-Breast01 Matters

1+ week, 5+ day ago   (1476+ words) Eventually, however, many patients reach a point at which endocrine-based strategies have been exhausted and chemotherapy becomes necessary. That is the setting in which izalontamab brengitecan (iza-bren; BL-B01D1) is now generating considerable interest. On August 26, 2026, Sichuan Biokin Pharmaceutical announced that…...

Oncodaily - Oncology News
oncodaily.com > voices > maryam-lustberg-574355

Maryam Lustberg: Welcoming Mitchell Elliott to Our Breast Cancer's Team - OncoDaily

2+ week, 4+ day ago   (106+ words) OncoDaily is a specialized news and information platform that provides daily updates on oncology research, treatments, clinical trials, and advancements in cancer care. It serves healthcare professionals, researchers, and patients by delivering timely and accurate insights into the latest developments…...

Oncodaily - Oncology News
oncodaily.com > voices > monika-pansari-574225

Monika Pansari: A Breast Lump Is Not Always Cancer - OncoDaily

2+ week, 5+ day ago   (110+ words) Monika Pansari, Lead Breast and GYN Oncosurgeon (Senior Surgical Oncologist) at Manipal Hospital, shared on LinkedIn: “Is every breast lump cancer? No. Finding a lump in your breast can be scary, but not every breast lump is cancerous. Cysts, fibroadenomas…...

Oncodaily - Oncology News
oncodaily.com > science > victor-moreno-574186

Victor Moreno: PD-1/VEGF Bispecifics Move Into Triple-Negative Breast Cancer - OncoDaily

2+ week, 5+ day ago   (229+ words) Victor Moreno, Director of Clinical Research at START Madrid FJD, shared on LinkedIn: “PD-1/VEGF bispecific antibodies are moving beyond lung cancer. Could triple-negative breast cancer be another setting where this makes sense? A recently published multicentre phase 2 trial evaluated…...

Oncodaily - Oncology News
oncodaily.com > oncolibrary > breast-oncology > oncotype-dx

Oncotype DX-Guided Chemotherapy Associated With Improved Survival in HR+/HER2− Breast Cancer - OncoDaily

2+ week, 5+ day ago   (495+ words) The study, published in The Breast, evaluated whether chemotherapy selection supported by the Oncotype DX recurrence score was associated with differences in overall survival compared with physician-directed chemotherapy decisions without genomic testing. The findings highlight the growing role of genomic…...

Oncodaily - Oncology News
oncodaily.com > voices > muna-al-khaifi-571473

Muna Al-Khaifi: Proud of Student’s Award-Winning Research on Gaps in Breast Cancer Survivorship Care - OncoDaily

2+ week, 6+ day ago   (225+ words) Muna Al-Khaifi, GP oncologist at Mount Sinai Hospital (Toronto), Sinai Health, shared on LinkedIn: “I’m very proud of my summer research student, Jashmira Bhinder, who won First Place in the Poster Presentation at the Osler Research Institute Summer Student Research…...

Google News
oncodaily.com > insight > kefah-mokbel-572728

Kefah Mokbel: MRI Response Could Redefine Radiotherapy Decisions in Breast Cancer

2+ week, 6+ day ago   (165+ words) Kefah Mokbel, Chair of Breast Cancer Surgery at London Breast Institute, shared on LinkedIn: “New study: MRI response may help personalize internal mammary node radiotherapy after neoadjuvant therapy A new study by Yushuo Peng and colleagues, published online in International…...

Oncodaily - Oncology News
oncodaily.com > voices > amalia-mara-rosu-570511

Amalia Mara Rosu: Beyond Tumor Biology: What Young Women with Breast Cancer Have Taught Me - OncoDaily

3+ week, 1+ day ago   (502+ words) Amalia Mara Rosu, Medical Oncologist at Ponderas Academic Hospital in Bucharest, Romania, shared an article with OncoDaily reflecting on the evolving role of precision oncology and the importance of placing patients’ priorities at the center of cancer care. In her…...